Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report

Cucunawangsih Cucunawangsih, Andree Kurniawan, Nata Pratama Hardjo Lugito.




Abstract
Cited by 0 Articles

Micafungin is an echinocandin-class antifungal agent that is extremely used in the recent era due to minimal toxicity and broad-spectrum activity, unfortunately has limited ability against Cryptococcus neoformans. Since it’s inherently resistant, indeed disseminated invasive cryptococcosis is becoming an important issue in echinocandin recipient with impaired immunity. We present a patient with systemic lupus erythematosus and miliary tuberculosis, who developed a fungal infection with invasive cryptococcal fungemia during empirical micafungin therapy. To the best of our knowledge, breakthrough disseminated cryptococcosis has not been reported, as seen in our patient. This case highlighted that Cryptococcus neoformans infection should be kept in mind as a possible breakthrough infection while receiving echinocandin, especially in patients with cellular immunodeficiency.

Key words: invasive fungal infection, micafungin, Cryptococcus neoformans






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.